A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer

by Sundar, R, Rha, S.Y, Yamaue, H, Katsuda, M, Kono, K, Kim, H.S, Kim, C, Mimura, K, Kua, L.-F, Yong, W.P
Published 2020

Nimesulide and celecoxib inhibits multiple oncogenic pathways in gastric cancer cells

by Periasamy, J., Muthuswami, M., Ramesh, V., Muthusamy, T., Jain, A., Karthikeyan, C., Trivedi, P., Kumar, R.S., Gunasekaran, P., Rha, S.Y., Tan, P., Kumaresan, G.
Published 2014

A densely interconnected genome-wide network of micrornas and oncogenic pathways revealed using gene expression signatures

by Ooi, C.H., Oh, H.K., Wang, H.Z., Tan, A.L.K., Wu, J., Lee, M., Rha, S.Y., Chung, H.C., Virshup, D.M., Tan, P.
Published 2014

Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer

by Oh, H.-K., Tan, A.L.-K., Das, K., Ooi, C.-H., Deng, N.-T., Tan, I.B., Beillard, E., Lee, J., Ramnarayanan, K., Rha, S.-Y., Palanisamy, N., Voorhoeve, P.M., Tan, P.
Published 2014

Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement

by Kim, H.R., Shim, H.S., Chung, J.-H., Lee, Y.J., Hong, Y.K., Rha, S.Y., Kim, S.H., Ha, S.-J., Kim, S.K., Chung, K.Y., Soo, R., Kim, J.H., Cho, B.C.
Published 2014

Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer

by Ivanova, T., Zouridis, H., Wu, Y., Cheng, L.L., Tan, I.B., Gopalakrishnan, V., Ooi, C.H., Lee, J., Qin, L., Wu, J., Lee, M., Rha, S.Y., Huang, D., Liem, N., Yeoh, K.G., Yong, W.P., Teh, B.T., Tan, P.
Published 2014

Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer

by Kim, H.R., Kim, D.J., Kang, D.R., Lee, J.G., Lim, S.M., Lee, C.Y., Rha, S.Y., Bae, M.K., Lee, Y.J., Kim, S.H., Ha, S.-J., Soo, R.A., Chung, K.Y., Kim, J.H., Lee, J.H., Shim, H.S., Cho, B.C.
Published 2014

CD44-SLC1A2 gene fusions in gastric cancer

by Tao, J., Deng, N.T., Ramnarayanan, K., Huang, B., Oh, H.K., Leong, S.H., Lim, S.S., Tan, I.B., Ooi, C.H., Wu, J., Lee, M., Zhang, S., Rha, S.Y., Chung, H.C., Smoot, D.T., Ashktorab, H., Kon, O.L., Cacheux, V., Yap, C., Palanisamy, N., Tan, P.
Published 2014

Irofulven as first line therapy in recurrent or metastatic gastric cancer: A phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)

by Yeo, W., Zee, B., Ma, B., Lam, K.C., Mo, F.K.F., Ng, E.K.W., Ho, R., Chan, A.T.C., Yeo, W., Boyer, M., Clarke, S., Beale, P., Chung, H.C., Roh, J.K., Rha, S.Y., Jeung, H.C., Ong, S.Y.K., Lim, R., Soo, R., Goh, B.C.
Published 2011

Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer

by Wu, Y., Grabsch, H., Ivanova, T., Tan, I.B., Murray, J., Ooi, C.H., Wright, A.I., West, N.P., Hutchins, G.G.A., Wu, J., Lee, M., Lee, J., Koo, J.H., Yeoh, K.G., Van Grieken, N., Ylstra, B., Rha, S.Y., Ajani, J.A., Cheong, J.H., Noh, S.H., Lim, K.H., Boussioutas, A., Lee, J.-S., Tan, P.
Published 2014

Oncogenic pathway combinations predict clinical prognosis in gastric cancer

by Ooi, C.H., Tan, P., Ivanova, T., Wu, J., Lee, M., Tao, J., Koo, J.H., Gopalakrishnan, V., Zhu, Y., Lee, J., Ganesan, K., Tan, I.B., Tao, J., Ward, L., Grabsch, H., Cheng, L.L., Rha, S.Y., Chung, H.C., So, J., Soo, K.C., Lim, D., Chan, W.H., Wong, W.K., Bowtell, D., Boussioutas, A., Yeoh, K.G.
Published 2011

Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors fr...

by Yeo, W., Chung, H.C., Chan, S.L., Wang, L.Z., Lim, R., Picus, J., Boyer, M., Mo, F.K.F., Koh, J., Rha, S.Y., Hui, E.P., Jeung, H.C., Roh, J.K., Yu, S.C.H., To, K.F., Tao, Q., Ma, B.B., Chan, A.W.H., Tong, J.H.M., Erlichman, C., Chan, A.T.C., Goh, B.C.
Published 2014

A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets

by Deng, N., Goh, L.K., Wang, H., Das, K., Tao, J., Tan, I.B., Zhang, S., Lee, M., Wu, J., Lim, K.H., Lei, Z., Goh, G., Lim, Q.-Y., Tan, A.L.-K., Poh, D.Y.S., Riahi, S., Bell, S., Shi, M.M., Linnartz, R., Zhu, F., Yeoh, K.G., Toh, H.C., Yong, W.P., Cheong, H.C., Rha, S.Y., Boussioutas, A., Grabsch, H., Rozen, S., Tan, P.
Published 2014

Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy

by Tan, I.B., Ivanova, T., Lim, K.H., Ong, C.W., Deng, N., Lee, J., Tan, S.H., Wu, J., Lee, M.H., Ooi, C.H., Rha, S.Y., Wong, W.K., Boussioutas, A., Yeoh, K.G., So, J., Yong, W.P., Tsuburaya, A., Grabsch, H., Toh, H.C., Rozen, S., Cheong, J.H., Noh, S.H., Wan, W.K., Ajani, J.A., Lee, J., Tellez, M.S., Tan, P.
Published 2014

Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity

by Ooi, W.F, Xing, M, Xu, C, Yao, X, Ramlee, M.K, Lim, M.C, Cao, F, Lim, K, Babu, D, Poon, L.-F, Lin Suling, J, Qamra, A, Irwanto, A, Qu Zhengzhong, J, Nandi, T, Lee-Lim, A.P, Chan, Y.S, Tay, S.T, Lee, M.H, Davies, J.O.J, Wong, W.K, Soo, K.C, Chan, W.H, Ong, H.S, Chow, P, Wong, C.Y, Rha, S.Y, Liu, J, Hillmer, A.M, Hughes, J.R, Rozen, S, Teh, B.T, Fullwood, M.J, Li, S, Tan, P
Published 2020

Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes

by Zang, Z.J., Cutcutache, I., Poon, S.L., Zhang, S.L., Mcpherson, J.R., Tao, J., Rajasegaran, V., Heng, H.L., Deng, N., Gan, A., Lim, K.H., Ong, C.K., Huang, D., Chin, S.Y., Tan, I.B., Ng, C.C.Y., Yu, W., Wu, Y., Lee, M., Wu, J., Poh, D., Wan, W.K., Rha, S.Y., So, J., Salto-Tellez, M., Yeoh, K.G., Wong, W.K., Zhu, Y.-J., Futreal, P.A., Pang, B., Ruan, Y., Hillmer, A.M., Bertrand, D., Nagarajan, N., Rozen, S., Teh, B.T., Tan, P.
Published 2013